Biotage AB (STU:PQX1) 3-Year Revenue Growth Rate : 14.50% (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Biotage AB 3-Year Revenue Growth Rate?

Biotage AB's Revenue per Share for the three months ended in Mar. 2024 was €0.53.

During the past 12 months, Biotage AB's average Revenue per Share Growth Rate was 9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Biotage AB was 30.30% per year. The lowest was -10.70% per year. And the median was 12.30% per year.

Competitive Comparison of Biotage AB's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Biotage AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Biotage AB's 3-Year Revenue Growth Rate falls into.

Biotage AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Biotage AB (STU:PQX1) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Biotage AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Biotage AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (STU:PQX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (STU:PQX1) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (STU:PQX1) Headlines

No Headlines